Pre-Seed
$1.0M – $4.5M
$104M
1+ companies
1 partner
Investment Thesis
Supports innovative hospitality concepts with a focus on premium experiences and wellness integration.
Meet the Team
Jeff Bird has been a life sciences investor for nearly twenty years at Sutter Hill Ventures. In 2019, he formed Bluebird Ventures. Jeff most recently served on the boards of two public companies, Portola Pharmaceuticals and Forty Seven, Inc. Jeff served as CEO of Verinata Health, a developer of non-invasive prenatal diagnostics which was sold to Illumina. Prior to Sutter Hill Ventures, Jeff was an executive at Gilead Sciences for 12 years, most recently as Senior Vice President of Business Operations which included global sales and marketing. Jeff received MD and PhD (Cancer Biology) degrees from Stanford Medical School and was a Stanford undergraduate.
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (1)
Other
Mind Retreat
- •Raising at Pre-Seed? You're squarely in their sweet spot.
- •Lead with your fit in Other, Healthcare — the sectors they actively back.
- •Size your ask to their typical $1.0M – $4.5M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Jeff Bird, General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Bluebird Ventures is a match for your startup
Upload your pitch deck to see how well you match with Bluebird Ventures and 10,000+ other investors.
Is this your profile? Request a correction or removal